Brief: Emergent Biosolutions Secures $62.4 Million Contract Modification
23/06/2025 13:21
June 23 (Reuters) - Emergent BioSolutions Inc EBS.N: EMERGENT BIOSOLUTIONS SECURES $62.4 MILLION CONTRACT MODIFICATION FOR BAT® [BOTULISM ANTITOXIN HEPTAVALENT (A, B, C, D, E, F, G) – (EQUINE)] TO BOLSTER U.S. BIODEFENSE SUPPLY Source text: ID:nGNX3G4xvH Further company coverage: EBS.N ((Reuters.Briefs@thomsonreuters.com;))